Mercury Laboratories (BOM:538964) Total Receivables: ₹0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:538964 Mercury Laboratories Ltd BOM:538964
76 GF Score
Price ₹812.50
GF Value ₹832.71
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Mercury Laboratories Total Receivables?

Mercury Laboratories BOM:538964 +4.57% 76 Total Receivables is ₹0.0 Mil as of Jun. 2026. GuruFocus rates BOM:538964 with a GF Score™ of 76/100 and a GF Value™ of ₹832.71 (Fairly Valued). The stock has 5 warning signs investors should review.

Mercury Laboratories's Total Receivables for the quarter that ended in Jun. 2026 was ₹0.0 Mil.

Mercury Laboratories Total Receivables Related Terms

Mercury Laboratories Total Receivables Historical Data

* Premium members only.

The historical data trend for Mercury Laboratories's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mercury Laboratories Total Receivables Chart

Mercury Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 167.76 214.01 219.34 257.97 258.46

Mercury Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 250.24 0.00 258.46 0.00
BOM:538964
76GF Score
Mercury Laboratories Ltd BOM:538964
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mercury Laboratories Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of ₹0.0 Mil mean?
Mercury Laboratories (BOM:538964) has a Total Receivables of ₹0.0 Mil as of Jun. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Mercury Laboratories and its competitors.
Is Mercury Laboratories' Total Receivables too high?
Mercury Laboratories' current Total Receivables is ₹0.0 Mil. Overall, Mercury Laboratories has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Mercury Laboratories' Total Receivables compare to ZTS?
Mercury Laboratories' Total Receivables of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Drug Manufacturers company?
A good Total Receivables depends on the Drug Manufacturers industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Mercury Laboratories and its competitors. Mercury Laboratories's current Total Receivables is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercury Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Mercury Laboratories (BOM:538964) is currently considered Fairly Valued. The stock's GF Value™ is ₹832.71, compared to a current price of ₹812.50 — trading 2.4% below its estimated fair value. The current Total Receivables is ₹0.0 Mil. Mercury Laboratories' overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Mercury Laboratories (BOM:538964), the current Total Receivables is ₹0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mercury Laboratories (BOM:538964) Overvalued in 2026?

Based on GuruFocus' analysis, Mercury Laboratories stock appears to be undervalued. The current stock price of ₹812.50 is trading 2.4% below its estimated GF Value™ of ₹832.71. GuruFocus considers Mercury Laboratories to be Fairly Valued.

Key valuation signals for BOM:538964:

  • Total Receivables: ₹0.0 Mil
  • GF Value™: ₹832.71 vs. price of ₹812.50 (2.4% below fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the BOM:538964 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mercury Laboratories Business Description

Address Gorwa Road, 2/13-14, Gorwa Industrial estate, P.B. No. 3001, Vadodara, GJ, IND, 390016
Mercury Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and distribution of pharmaceutical drugs, herbs, and laboratory and surgical materials. The group produces medicines and formulations in the segments of pediatrics, obstetrics, gynecology, surgeon segment, multivitamin and nutrition supplements, antibiotics, and others. The company sells its products in India and Internationally, of which key revenue is derived from sales made in India.
76GF Score

Get the complete analysis for BOM:538964

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹812.50
Price
₹832.71
GF Value